The US Food and Drug Administration (FDA) has released the text of a Form 483 sent to biopharmaceutical manufacturer Biogen Idec, outlining a series of alleged deficiencies affecting the manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results